NDC 67046-169

Pharbest Aspirin 325mg

Aspirin

Pharbest Aspirin 325mg is a Oral Tablet, Delayed Release in the Human Otc Drug category. It is labeled and distributed by Contract Pharmacy Services-pa. The primary component is Aspirin.

Product ID67046-169_59c703f4-328b-44fa-e053-2991aa0a3e2e
NDC67046-169
Product TypeHuman Otc Drug
Proprietary NamePharbest Aspirin 325mg
Generic NameAspirin
Dosage FormTablet, Delayed Release
Route of AdministrationORAL
Marketing Start Date2017-09-22
Marketing CategoryOTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL
Application Numberpart343
Labeler NameContract Pharmacy Services-PA
Substance NameASPIRIN
Active Ingredient Strength325 mg/1
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 67046-169-07

7 TABLET, DELAYED RELEASE in 1 BLISTER PACK (67046-169-07)
Marketing Start Date2017-09-22
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 67046-169-28 [67046016928]

Pharbest Aspirin 325mg TABLET, DELAYED RELEASE
Marketing CategoryOTC monograph final
Application Numberpart343
Product TypeHUMAN OTC DRUG
Marketing Start Date2017-09-22

NDC 67046-169-21 [67046016921]

Pharbest Aspirin 325mg TABLET, DELAYED RELEASE
Marketing CategoryOTC monograph final
Application Numberpart343
Product TypeHUMAN OTC DRUG
Marketing Start Date2017-09-22

NDC 67046-169-14 [67046016914]

Pharbest Aspirin 325mg TABLET, DELAYED RELEASE
Marketing CategoryOTC monograph final
Application Numberpart343
Product TypeHUMAN OTC DRUG
Marketing Start Date2017-09-22

NDC 67046-169-15 [67046016915]

Pharbest Aspirin 325mg TABLET, DELAYED RELEASE
Marketing CategoryOTC monograph final
Application Numberpart343
Product TypeHUMAN OTC DRUG
Marketing Start Date2017-09-22

NDC 67046-169-20 [67046016920]

Pharbest Aspirin 325mg TABLET, DELAYED RELEASE
Marketing CategoryOTC monograph final
Application Numberpart343
Product TypeHUMAN OTC DRUG
Marketing Start Date2017-09-22

NDC 67046-169-30 [67046016930]

Pharbest Aspirin 325mg TABLET, DELAYED RELEASE
Marketing CategoryOTC monograph final
Application Numberpart343
Product TypeHUMAN OTC DRUG
Marketing Start Date2017-09-22

NDC 67046-169-60 [67046016960]

Pharbest Aspirin 325mg TABLET, DELAYED RELEASE
Marketing CategoryOTC monograph final
Application Numberpart343
Product TypeHUMAN OTC DRUG
Marketing Start Date2017-09-22

NDC 67046-169-07 [67046016907]

Pharbest Aspirin 325mg TABLET, DELAYED RELEASE
Marketing CategoryOTC monograph final
Application Numberpart343
Product TypeHUMAN OTC DRUG
Marketing Start Date2017-09-22

Drug Details

Active Ingredients

IngredientStrength
ASPIRIN325 mg/1

OpenFDA Data

SPL SET ID:59c703f4-328a-44fa-e053-2991aa0a3e2e
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 198467
  • Pharm Class PE
  • Decreased Prostaglandin Production [PE]
  • Decreased Platelet Aggregation [PE]
  • PHarm Class EPC
  • Nonsteroidal Anti-inflammatory Drug [EPC]
  • Platelet Aggregation Inhibitor [EPC]
  • UPC Code
  • 0016103357118
  • NUI Code
  • N0000008832
  • N0000008836
  • N0000175721
  • N0000000160
  • N0000175578
  • N0000175722
  • NDC Crossover Matching brand name "Pharbest Aspirin 325mg" or generic name "Aspirin"

    NDCBrand NameGeneric Name
    16103-357Pharbest Aspirin 325mgPharbest Aspirin 325mg
    50090-0004Pharbest Aspirin 325mgPharbest Aspirin 325mg
    67046-169Pharbest Aspirin 325mgPharbest Aspirin 325mg
    0363-0157AspirinAspirin
    0363-0218AspirinAspirin
    0363-0227AspirinAspirin
    0113-0773Basic Care AspirinAspirin
    0113-7467basic care aspirinAspirin
    0280-2100BayerAspirin
    0280-2110Bayer Aspirin RegimenAspirin
    0280-2080Bayer Aspirin Regimen ChewableAspirin
    0280-2090Bayer Chewable - Aspirin RegimenAspirin
    0280-2000Bayer Genuine AspirinAspirin
    0280-2040Bayer PlusAspirin
    0280-2200Bayer WomensAspirin
    0067-6424BUFFERINASPIRIN
    0113-0259good sense aspirinAspirin
    0113-0274Good Sense aspirinAspirin
    0113-0416good sense aspirinAspirin
    0113-0467good sense aspirinAspirin
    0113-1919Good Sense Aspirinaspirin
    0363-0183Regular Strength Tri-Buffered AspirinAspirin

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.